13F filer · CIK 1422849 ↗

Capital World Investors

You are looking at Q3 2018. See the latest, Q2 2026 →

Reported value

$411.05B

−12% on the quarter before

Positions

556

83 new · 65 sold out

Top 10

24.2%

of the value

Est. gain

+$19.43B

on stocks held all quarter

Est. return

+5.5%

on those stocks since Q2 2018

Filed

Nov 14, 2018

On SEC EDGAR ↗

Positions as of Sep 30, 2018, from Capital World Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 40% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2018. Striped tiles are options.

Microsoft5.2%
Home Depot Inc2.9%
Broadcom2.6%Amazon2.5%
Unitedhealth Group Inc2.5%
Dowdupont Inc2.1%
Berkshire Hathaway Inc Cl A1.8%
Jpmorgan Chase And Co1.8%
Intel1.5%
Merck And Co Inc1.5%
Boeing Co1.4%
Lockheed Martin Corp1.4%
Nike Inc Cl B1.3%
Meta1.3%
Philip Morris International1.3%
Conocophillips1.2%
Cme Group Inc Cl A1.2%
Alphabet1.1%
Royal Dutch Shell Plc B ADR1.1%
Mastercard1.0%Alphabet1.0%BlackRock1.0%
Verizon Communications Inc0.9%
Netflix0.9%

Largest buys

Since Q2 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Pfizer Inc~$2.08BAdded · 0.3% → 0.9%+47,202,436 shares
  2. Csx Corp~$2.02BAdded · 0.0% → 0.5%+27,231,204 shares
  3. Micron~$1.14BNew · 0.0% → 0.3%+25,126,943 shares
  4. Abbvie Inc~$1.03BAdded · 0.3% → 0.6%+10,858,432 shares
  5. Amgen Inc~$952.9MNew · 0.0% → 0.2%+4,596,943 shares
  6. Marriott International Inc Cl A~$942.7MAdded · 0.0% → 0.3%+7,140,319 shares
  7. Intercontinental Exchange Inc~$926.4MAdded · 0.0% → 0.3%+12,370,546 shares
  8. Exxon Mobil Corp~$917.9MAdded · 0.0% → 0.2%+10,796,373 shares
  9. Canadian Natural Resources Ltd~$739.6MAdded · 0.1% → 0.3%+22,638,074 shares
  10. Biogen Inc~$729.1MAdded · 0.0% → 0.2%+2,063,598 shares

Largest sells

Since Q2 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Amazon~$9.28BCut · 3.5% → 2.5%−4,631,661 shares
  2. Microsoft~$7.62BCut · 5.3% → 5.2%−66,666,910 shares
  3. Wells Fargo And Co~$5.75BCut · 2.0% → 0.7%−109,348,329 shares
  4. Meta~$3.85BCut · 2.4% → 1.3%−23,432,423 shares
  5. Intel~$3.74BCut · 2.2% → 1.5%−79,115,233 shares
  6. Alphabet~$3.70BCut · 1.7% → 1.1%−3,102,979 shares
  7. Comcast Corp Cl A~$3.20BCut · 1.2% → 0.7%−90,504,990 shares
  8. Aetna Inc~$2.87BCut · 0.9% → 0.4%−14,126,734 shares
  9. Praxair Inc~$2.84BSold out · 0.6% → 0.0%−17,935,336 shares
  10. Humana Inc~$2.83BCut · 0.7% → 0.3%−8,370,596 shares

Holdings

As of Sep 30, 2018. Changes are in shares against Jun 30, 2018, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
MicrosoftCOMMON STOCK · shares −26% · price +16.0%5.2%$21.21B+$2.92B
Home Depot IncCOMMON STOCK · shares −0.6% · price +6.2%2.9%$11.77B+$684.7M
BroadcomCOMMON STOCK · shares −13% · price +1.7%2.6%$10.50B+$174.1M
AmazonCOMMON STOCK · shares −48% · price +17.8%2.5%$10.22B+$1.55B
Unitedhealth Group IncCOMMON STOCK · shares −9.7% · price +8.4%2.5%$10.18B+$792.4M
Dowdupont IncCOMMON STOCK · shares +2.6% · price −2.4%2.1%$8.47B−$206.5M
Berkshire Hathaway Inc Cl ACOMMON STOCK · shares −4.1% · price +13.5%1.8%$7.24B+$859.1M
Jpmorgan Chase And CoCOMMON STOCK · shares −3.5% · price +8.3%1.8%$7.22B+$553.2M
IntelCOMMON STOCK · shares −37% · price −4.9%1.5%$6.26B−$320.2M
Merck And Co IncCOMMON STOCK · shares −17% · price +16.9%1.5%$6.19B+$894.0M
Boeing CoCOMMON STOCK · shares −2.3% · price +10.8%1.4%$5.84B+$571.1M
Lockheed Martin CorpCOMMON STOCK · shares −4.4% · price +17.1%1.4%$5.72B+$835.4M
Nike Inc Cl BCOMMON STOCK · shares −14% · price +6.3%1.3%$5.50B+$327.0M
MetaCOMMON STOCK · shares −41% · price −15.4%1.3%$5.46B−$991.4M
Philip Morris InternationalCOMMON STOCK · shares −14% · price +1.0%1.3%$5.22B+$51.2M
ConocophillipsCOMMON STOCK · shares +2.4% · price +11.2%1.2%$5.11B+$501.1M
Cme Group Inc Cl ACOMMON STOCK · shares −7.8% · price +3.8%1.2%$4.92B+$181.8M
AlphabetCOMMON STOCK · shares −44% · price +7.0%1.1%$4.64B+$302.3M
Royal Dutch Shell Plc B ADRCOMMON STOCK · shares −23% · price −2.4%1.1%$4.37B−$105.9M
MastercardCOMMON STOCK · shares +18% · price +13.3%1.0%$4.26B+$421.6M
AlphabetCOMMON STOCK · shares −24% · price +6.9%1.0%$4.14B+$267.4M
BlackRockCOMMON STOCK · shares +1.8% · price −5.6%0.96%$3.94B−$227.4M
Verizon Communications IncCOMMON STOCK · shares +9.9% · price +6.1%0.93%$3.83B+$201.0M
NetflixCOMMON STOCK · shares +4.6% · price −4.4%0.93%$3.81B−$168.6M
Coca-Cola CoCOMMON STOCK · shares −33% · price +5.3%0.92%$3.79B+$191.1M
Total · 556 positions100%$411.05B+$19.43B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q2 2018 to Q3 2018: 466 stocks held throughout, up $19.43B (+5.5%).

  1. Microsoft+$2.92B+16%
  2. Amazon+$1.55B+18%
  3. Merck And Co Inc+$894.0M+17%
  4. Berkshire Hathaway Inc Cl A+$859.1M+13%
  5. Lockheed Martin Corp+$835.4M+17%
  6. Ryanair Holdings Plc ADR−$340.5M−16%
  7. Enbridge Inc−$343.3M−10%
  8. General Motors Company−$416.5M−15%
  9. Tesla−$476.2M−23%
  10. Meta−$991.4M−15%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$900.00B$450.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$846.43B+15%SEC ↗
Q1 2026$732.94B−0%SEC ↗
Q4 2025$735.30B+0%SEC ↗
Q3 2025$732.04B+6%SEC ↗
Q2 2025$687.95B+11%SEC ↗
Q1 2025$617.20B−6%SEC ↗
Q4 2024$658.71B+2%SEC ↗
Q3 2024$645.05B+5%SEC ↗
Q2 2024$613.27B+1%SEC ↗
Q1 2024$604.23B+7%SEC ↗
Q4 2023$562.26B+11%SEC ↗
Q3 2023$504.81B−3%SEC ↗
Q2 2023$519.91B+7%SEC ↗
Q1 2023$483.79B+3%SEC ↗
Q4 2022$469.11B+5%SEC ↗
Q3 2022$445.41B−5%SEC ↗
Q2 2022$470.72B−19%SEC ↗
Q1 2022$580.76B−8%SEC ↗
Q4 2021$632.21B+8%SEC ↗
Q3 2021$585.85B−0%SEC ↗
Q2 2021$588.43B+9%SEC ↗
Q1 2021$541.07B+4%SEC ↗
Q4 2020$518.94B+14%SEC ↗
Q3 2020$456.91B+11%SEC ↗
Q2 2020$413.27B+20%SEC ↗
Q1 2020$344.62B−23%SEC ↗
Q4 2019$447.39B+8%SEC ↗
Q3 2019$415.21B−3%SEC ↗
Q2 2019$426.29B+3%SEC ↗
Q1 2019$412.39B+12%SEC ↗
Q4 2018$369.11B−10%SEC ↗
Q3 2018$411.05B−12%SEC ↗
Q2 2018$467.29B+5%SEC ↗
Q1 2018$444.21B−4%SEC ↗
Q4 2017$461.25B+4%SEC ↗
Q3 2017$441.49B+4%SEC ↗
Q2 2017$425.76B+2%SEC ↗
Q1 2017$418.31B+5%SEC ↗
Q4 2016$397.60B+3%SEC ↗
Q3 2016$384.55B+4%SEC ↗
Q2 2016$370.85B+2%SEC ↗
Q1 2016$361.93BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.